Population Pharmacokinetics of Metronidazole Evaluated Using Scavenged Samples from Preterm Infants
Open Access
- 1 April 2012
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (4), 1828-1837
- https://doi.org/10.1128/aac.06071-11
Abstract
Pharmacokinetic (PK) studies in preterm infants are rarely conducted due to the research challenges posed by this population. To overcome these challenges, minimal-risk methods such as scavenged sampling can be used to evaluate the PK of commonly used drugs in this population. We evaluated the population PK of metronidazole using targeted sparse sampling and scavenged samples from infants that were ≤32 weeks of gestational age at birth and 8 mg/liter was calculated. Monte Carlo simulations were performed to evaluate the adequacy of different dosing recommendations per gestational age group. Thirty-two preterm infants were enrolled: the median (range) gestational age at birth was 27 (22 to 32) weeks, postnatal age was 41 (0 to 97) days, postmenstrual age (PMA) was 32 (24 to 43) weeks, and weight was 1,495 (678 to 3,850) g. The final PK data set contained 116 samples; 104/116 (90%) were scavenged from discarded clinical specimens. Metronidazole population PK was best described by a 1-compartment model. The population mean clearance (CL; liter/h) was determined as 0.0397 × (weight/1.5) × (PMA/32) 2.49 using a volume of distribution ( V ) (liter) of 1.07 × (weight/1.5). The relative standard errors around parameter estimates ranged between 11% and 30%. On average, metronidazole concentrations in scavenged samples were 30% lower than those measured in scheduled blood draws. The majority of infants (>70%) met predefined pharmacodynamic efficacy targets. A new, simplified, postmenstrual-age-based dosing regimen is recommended for this population. Minimal-risk methods such as scavenged PK sampling provided meaningful information related to development of metronidazole PK models and dosing recommendations.Keywords
This publication has 20 references indexed in Scilit:
- Pediatric Drug LabelingJAMA, 2003
- Pharmacokinetics and metabolism of oral midazolam in preterm infantsBritish Journal of Clinical Pharmacology, 2002
- Simultaneous quantification of amoxycillin and metronidazole in plasma using high-performance liquid chromatography with photodiode array detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Pharmacokinetics and Pharmacodynamics of the Nitroimidazole AntimicrobialsClinical Pharmacokinetics, 1999
- Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infectionsThe Pediatric Infectious Disease Journal, 1992
- Bacteremia due to anaerobic bacteria in newborns.1990
- Pharmacokinetics of intravenous metronidazole in neonatesJournal of Pediatric Surgery, 1988
- Intravenous metronidazole in the newborn.Archives of Disease in Childhood, 1983
- Pharmacokinetics and tissue distribution of metronidazole in the newborn infantThe Journal of Pediatrics, 1982
- The pharmacokinetics of oral and intravenous metronidazole in manJournal of Antimicrobial Chemotherapy, 1979